Global Animal Health Partnering Terms and Agreements 2010 to 2016

Publisher Name :
Date: 01-Oct-2016
No. of pages: 306
Inquire Before Buying

"Delivery of this report will take 1-3 days after purchase."

Welcome to the Global Animal Health Partnering Terms and Agreements 2010 to 2016 report.

The report provides a detailed understanding and analysis of how and why companies enter Animal Health partnering deals. These deals tend to be multicomponent, starting with collaborative R&D, and proceed to commercialization of outcomes.

This report provides details of the latest Animal Health agreements announced in the life sciences since 2010.

The report takes the reader through a comprehensive review Animal Health deal trends, key players, top deal values, as well as deal financials, allowing the understanding of how, why and under what terms, companies are entering Animal Health partnering deals.

The report presents financial deal term values for Animal Health deals, listing by headline value, upfront payments, milestone payments and royalties, enabling readers to analyse and benchmark the financial value of deals.

The middle section of the report explores the leading dealmakers in the Animal Health partnering field; both the leading deal values and most active Animal Health dealmaker companies are reported allowing the reader to see who is succeeding in this dynamic dealmaking market.

One of the key highlights of the report is that over 400 online deal records of actual Animal Health deals, as disclosed by the deal parties, are included towards the end of the report in a directory format - by company A-Z, stage of development, deal type, therapy focus, and technology type - that is easy to reference. Each deal record in the report links via Weblink to an online version of the deal.

In addition, where available, records include contract documents as submitted to the Securities Exchange Commission by companies and their partners. Whilst many companies will be seeking details of the payment clauses, the devil is in the detail in terms of how payments are triggered - contract documents provide this insight where press releases and databases do not.

The initial chapters of this report provide an orientation of Animal Health dealmaking. Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview of the trends in Animal Health dealmaking since 2010, including details of headline, upfront, milestone and royalty terms.

Chapter 3 provides a review of the leading Animal Health deals since 2010. Deals are listed by headline value. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.

Chapter 4 provides a comprehensive listing of the top 25 most active companies in Animal Health dealmaking with a brief summary followed by a comprehensive listing of Animal Health deals announded by that company, as well as contract documents, where available.

Chapter 5 provides a comprehensive and detailed review of Animal Health partnering deals signed and announced since Jan 2010, where a contract document is available in the public domain. Each deal title links via Weblink to an online version of the deal record and contract document, providing easy access to each contract document on demand.

Chapter 6 provides a comprehensive and detailed review of Animal Health partnering deals signed and announced since Jan 2010. The chapter is organized by specific Animal Health technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each deal on demand.

A comprehensive series of appendices is provided organized by Animal Health partnering company A-Z, stage of development, deal type, and therapy focus. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each deal on demand.

The report also includes numerous tables and figures that illustrate the trends and activities in Animal Health partnering and dealmaking since 2010.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of Animal Health technologies and products.

Key benefits

Global Animal Health Partnering 2010-2016: Deal trends, players, financials and forecasts provides the reader with the following key benefits:

In-depth understanding of Animal Health deal trends since 2010

Access to headline, upfront, milestone and royalty data

Analysis of the structure of Animal Health agreements with real life case studies

Detailed access to actual Animal Health contracts entered into by leading biopharma companies

Identify most active Animal Health dealmakers since 2010

Insight into terms included in a Animal Health partnering agreement, with real world examples

Understand the key deal terms companies have agreed in previous deals

Undertake due diligence to assess suitability of your proposed deal terms for partner companies

Report scope

Global Animal Health Partnering 2010-2016: Deal trends, players, financials and forecasts is intended to provide the reader with an in-depth understanding and access to Animal Health trends and structure of deals entered into by leading companies worldwide.

Animal Health Partnering Terms and Agreements includes:

Trends in Animal Health dealmaking in the biopharma industry since 2010

Analysis of Animal Health deal structure

Access to headline, upfront, milestone and royalty data

Case studies of real-life Animal Health deals

Access to Animal Health contract documents

Leading Animal Health deals by value since 2010

Most active Animal Health dealmakers since 2010

In Global Animal Health Partnering 2010-2016: Deal trends, players, financials and forecasts, the available deals are listed by:

Company A-Z

Headline value

Stage of development at signing

Deal component type

Specific therapy target

Technology type

Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The Global Animal Health Partnering 2010-2016: Deal trends, players, financials and forecasts report provides comprehensive access to available deals and contract documents for over 400 Animal Health deals.

Analyzing actual contract agreements allows assessment of the following:

What are the precise rights granted or optioned?

What is actually granted by the agreement to the partner company?

What exclusivity is granted?

What is the payment structure for the deal?

How aresalesand payments audited?

What is the deal term?

How are the key terms of the agreement defined?

How are IPRs handled and owned?

Who is responsible for commercialization?

Who is responsible for development, supply, and manufacture?

How is confidentiality and publication managed?

How are disputes to be resolved?

Under what conditions can the deal be terminated?

What happens when there is a change of ownership?

What sublicensing and subcontracting provisions have been agreed?

Which boilerplate clauses does the company insist upon?

Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?

Which jurisdiction does the company insist upon for agreement law?

Global Animal Health Partnering Terms and Agreements 2010 to 2016

Table of Contents

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in Animal Health dealmaking
2.1. Introduction
2.2. Animal Health partnering over the years
2.3. Most active Animal Health dealmakers
2.4. Animal Health partnering by deal type
2.5. Animal Health partnering by therapy area
2.6. Animal Health partnering by technology type
2.7. Deal terms for Animal Health partnering
2.7.1 Animal Health partnering headline values
2.7.2 Animal Health deal upfront payments
2.7.3 Animal Health deal milestone payments
2.7.4 Animal Health royalty rates

Chapter 3 - Leading Animal Health deals
3.1. Introduction
3.2. Top Animal Health deals by value

Chapter 4 - Most active Animal Health dealmakers
4.1. Introduction
4.2. Most active Animal Health dealmakers
4.3. Most active Animal Health partnering company profiles

Chapter 5 - Animal Health contracts dealmaking directory
5.1. Introduction
5.2. Animal Health contracts dealmaking directory

Chapter 6 - Animal Health dealmaking by technology type

Chapter 7 - Partnering resource center
7.1. Online partnering
7.2. Partnering events
7.3. Further reading on dealmaking

Appendices
Appendix 1 - Animal Health deals by company A-Z
Appendix 2 - Animal Health deals by stage of development
Appendix 3 - Animal Health deals by deal type
Appendix 4 - Animal Health deals by therapy area
Appendix 5 - Deal type definitions
About Wildwood Ventures
Current Partnering
Current Agreements
Recent report titles from Current Partnering

List of Figures

Figure 1: Animal Health partnering since 2010
Figure 2: Active Animal Health dealmaking activity- 2010 to 2016
Figure 3: Animal Health partnering by deal type since 2010
Figure 4: Animal Health partnering by disease type since 2010
Figure 5: Animal Health partnering by technology type since 2010
Figure 6: Animal Health deals with a headline value
Figure 7: Animal Health deals with an upfront value
Figure 8: Animal Health deals with a milestone value
Figure 9: Animal Health deals with a royalty rate value
Figure 10: Top Animal Health deals by value since 2010
Figure 11: Most active Animal Health dealmakers 2010 to 2016
Figure 12: Online partnering resources
Figure 13: Forthcoming partnering events
  • Global Tylosin Sales Market by Manufacturers, Regions, Type and Application, Forecast to 2021
    Published: 01-Dec-2016        Price: US 3480 Onwards        Pages: 114
    Tylosin is a macrolide-class broad spectrum antibiotic that's used in veterinary medicine to treat felines, canines and livestock. It is also active against some Gram-negative bacteria, spriochetes, some rickettsia and chlamydia. The drug is only used as an antibiotic in the treatment of infections in livestock.Scope of the Report:This report focuses on the Tylosin Sales in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and ......
  • Global Veterinary Drugs Sales Market Report 2016
    Published: 29-Nov-2016        Price: US 4000 Onwards        Pages: 108
    Notes: Sales, means the sales volume of Veterinary Drugs Revenue, means the sales value of Veterinary Drugs This report studies sales (consumption) of Veterinary Drugs in Global market, especially in United States, China, Europe, Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering - Zoetis(Pfizer) - MERIAL - Merial - Lilly - Bayer - B......
  • Global Tylosin Market by Manufacturers, Regions, Type and Application, Forecast to 2021
    Published: 10-Nov-2016        Price: US 3480 Onwards        Pages: 111
    Tylosin is a macrolide-class broad spectrum antibiotic that's used in veterinary medicine to treat felines, canines and livestock. However, the drug is only used as an antibiotic in the treatment of infections in livestock. In cats, dogs, and other smaller animals, Technology is used predominantly for Technologys anti-inflammatory properties to treat inflammatory condTechnologyions in the bowel. As such, Technology is commonly prescribed to pets that are suffering from diarrhea. ......
  • 2016 Global and Chinese Veterinary Medicine Industry Market Research Report
    Published: 09-Nov-2016        Price: US 2800 Onwards        Pages: 150
    The 'Global and Chinese Veterinary Medicine Industry, 2011-2021 Market Research Report' is a professional and in-depth study on the current state of the global Veterinary Medicine industry with a focus on the Chinese market. The report provides key statistics on the market status of the Veterinary Medicine manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Firstly, the report provides a basic overview of the industry includi......
  • Global Porcine Serum Sales Market Report 2016
    Published: 26-Oct-2016        Price: US 4000 Onwards        Pages: 112
    Notes: Sales, means the sales volume of Porcine Serum Revenue, means the sales value of Porcine Serum This report studies sales (consumption) of Porcine Serum in Global market, especially in United States, China, Europe, Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering - Thermo Fisher Scientific - Sigma-Aldrich - Bio-Rad - Fitzgerald Industries......
  • United States Animal Antimicrobials and Antibiotics Market Report 2016
    Published: 26-Oct-2016        Price: US 3800 Onwards        Pages: 107
    Notes: Sales, means the sales volume of Animal Antimicrobials and Antibiotics Revenue, means the sales value of Animal Antimicrobials and Antibiotics This report studies sales (consumption) of Animal Antimicrobials and Antibiotics in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering - Zoetis - Elanco - Merck Animal Health - Merial - Bayer Animal Health - Vi......
  • China Foot and Mouth Disease (FMD) Vaccines Market by Manufacturers, Type and Application, Forecast to 2021
    Published: 24-Oct-2016        Price: US 4480 Onwards        Pages: 101
    Foot and Mouth Disease Vaccine is one of the most important weapons to prevent and control the occurrence and prevalence of foot and mouth disease. The vaccine should be allowed to have a small amount of oil emulsion, precipitate or emulsion in this column can be layered, shake gently to make the emulsion recovery even after use. In case of breaking or exceed the stratification (aqueous secretion according to the rules of not more than 1/10) is not available. The vaccine should be protected from......
  • United States Animal Health Market Report 2016
    Published: 24-Oct-2016        Price: US 3800 Onwards        Pages: 111
    Notes: Sales, means the sales volume of Animal Health Revenue, means the sales value of Animal Health This report studies sales (consumption) of Animal Health in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering - Bayer - Merial - Virbac - Bupo Animal Health - Lion Bridge - Afrivet - Â… Split by product types, with sales, revenue, price......
  • Asia-Pacific Animal Health Market by Product (Parasiticides (Endoparasiticides, Ectoparasiticides), Antimicrobial & Antibiotic, Vaccines, Feed Additive (Vitamin, Amino Acids, Antioxidant), Growth Promoter), Animal (Livestock, Companion) - Forecast to 2021
    Published: 21-Oct-2016        Price: US 5650 Onwards        Pages: 199
    The APAC animal health market is estimated to grow at a CAGR of 5.7% during the forecast period, to reach USD 20.25 billion by 2021 from USD 15.32 billion in 2016. Growth in this market can primarily be attributed to the rapid rise in livestock population, increasing awareness about animal health, rising demand for animal-derived food products, and rising frequency of animal disease outbreaks. However, restrictions on the use of parasitic ides in food-producing animals, the shift towards vege......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs